DiscoveRx Corporation Adds Key Kinase Assays to its Growing Portfolio of Cell Based Assays

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation, a leading provider of cell based GPCR and Kinase assays, today announced release of over 50 PhosphoQuest™ ELISA assays for detecting functional kinase activities in cells. “The launch of this product line signifies our commitment to support kinase research, assay development and screening markets. DiscoveRx now offers a comprehensive portfolio of products that addresses the drug discovery needs of exploring active and unactive purified kinases and now cell based kinases,” said Dr. Anna Christensen, DiscoveRx Product Manager for Kinases.